| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | Apr 3, 2025 | Beam Therapeutics Inc. | President | Sell | 37.5 | -7,434 | -3.76% | ✓ | $136.4K |
| Nov 6, 2024 | Nov 8, 2024 | Beam Therapeutics Inc. | President | Sell | 5.0 | -51,110 | -31.89% | ✓ | $1.3M |
| Oct 14, 2024 | Oct 16, 2024 | Beam Therapeutics Inc. | President | Sell | 10.0 | -51,110 | -24.18% | ✓ | $1.3M |
| Apr 1, 2024 | Apr 3, 2024 | Beam Therapeutics Inc. | President | Sell | 41.3 | -4,534 | -2.60% | ✓ | $145.6K |
| Jul 21, 2023 | Jul 25, 2023 | Beam Therapeutics Inc. | President | Sell | 3.8 | -156,530 | -61.86% | ✓ | $5M |
| Apr 3, 2023 | Apr 5, 2023 | Beam Therapeutics Inc. | President | Sell | 37.5 | -3,672 | -3.17% | ✓ | $109.2K |
| Jan 3, 2023 | Jan 5, 2023 | Beam Therapeutics Inc. | President | Sell | 5.0 | -53,729 | -35.89% | ✓ | $2M |
| Dec 12, 2022 | Dec 14, 2022 | Beam Therapeutics Inc. | President | Sell | 5.0 | -51,015 | -35.81% | ✓ | $2.2M |
| Mar 31, 2022 | Apr 4, 2022 | Beam Therapeutics Inc. | President | Sell | 95.0 | +13,141 | 12.82% | ✗ | $109.9K |
| Dec 22, 2021 | Dec 23, 2021 | Beam Therapeutics Inc. | President | Sell | 37.5 | -2,607 | -3.99% | ✓ | $224.5K |
| Dec 20, 2021 | Dec 22, 2021 | Beam Therapeutics Inc. | President | Sell | 20.0 | -29,393 | -12.99% | ✓ | $2.5M |
| Jun 28, 2021 | Jun 30, 2021 | Beam Therapeutics Inc. | President | Sell | 3.8 | -78,580 | -63.71% | ✓ | $8.4M |
| Dec 30, 2020 | Jan 4, 2021 | Beam Therapeutics Inc. | President | Sell | 5.0 | -43,842 | -92.16% | ✓ | $3.7M |